Clinical Trial Details
EORTC-55963
Back to Clinical Trials Database
A randomized phase III study for the treatment of recurrent epithelial ovarian cancer: Chemotherapy alone versus chemotherapy followed by secondary cytoreductive surgery in patients with a treatment-free interval of more than 12 months-trial 55963
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 07-Aug-2000 Date Step1 close: 30-Oct-2002 Date Step2 close: 21-Jan-2003 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 700 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00006356 |
| NCT number | NCT00006356 |
